Where's the postbox? advanced pharma intelligence The company raised its full year GAAP forecast and expectsrevenue of $4.31 billion and earnings of 77 cents per share,compared to its previously announced revenue of $4.22 billionand earnings of 73 cents per share. It maintained its non-GAAPforecast of $4.25 billion in revenue and earnings of 82 centsper share.